fda glp-1 warning news november 2025 The has received hundreds of adverse event reports tied to compounded GLP-1s. PRI's brief warns that patients should know the risks before trusting knockoff versions. Read the brief: https://medecon.org/unauthorized-glp-1-knockoffs/ FDA issued 25 warning letters
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective for weight loss but cause gastrointestinal side effects, affecting ...
While positive for consumers, it places significant financial pressure on an already brittle healthcare and Medicare ecosystem
A recent lawsuit has been filed against Novo Nordisk and Eli Lilly, the manufacturers of Ozempic and Mounjaro, two diabetes medications increasingly used off-label for weight loss

Find the correct ICD-10 codes for Mounjaro (tirzepatide) adverse effects, long-term use, and complications
When I compare GLP-1 prices across different brands, I notice significant variations that can really impact my wallet
